Residual Iris Retraction Syndrome After Artificial Iris Implantation.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
03 2019
Historique:
received: 23 03 2018
revised: 03 09 2018
accepted: 06 09 2018
pubmed: 22 9 2018
medline: 16 11 2019
entrez: 22 9 2018
Statut: ppublish

Résumé

To evaluate the effect of an artificial iris implant on the remnant iris. Interventional case series. Setting: Single center. Forty-two consecutive patients. Morphologic evaluation over 24 ± 14 months. Remnant pupillary aperture, iris color, visual acuity, intraocular pressure, and endothelial cell count. In 7 of 42 cases (16.7%), the residual iris aperture dilated from 36.6 ± 15.4 mm The implantation of an artificial iris prosthesis can lead to a residual iris retraction syndrome. It is likely that residual iris is trapped in the fissure between the artificial iris and the anterior chamber angle, preventing further pupil constriction. Another possibility could be a constriction or atrophy of the residual iris. A scleral-sutured implant and an implantation in the capsular bag were both found to prevent the iris retraction. The study group number is inadequate to allow statistical comparison of these different implantation methods. As the use of artificial irises increases, we may expect more patients with iris retraction syndrome in the future.

Identifiants

pubmed: 30236771
pii: S0002-9394(18)30520-8
doi: 10.1016/j.ajo.2018.09.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-166

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Christian S Mayer (CS)

Department of Ophthalmology, Technical University of Munich, Munich, Germany; David J. Apple Center for Vision Research, Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany. Electronic address: augenarzt.mayer@gmx.de.

Andrea E Laubichler (AE)

Department of Ophthalmology, Technical University of Munich, Munich, Germany.

Michael Masyk (M)

Department of Ophthalmology, Technical University of Munich, Munich, Germany.

Philipp Prahs (P)

Department of Ophthalmology, University of Regensburg, Regensburg, Germany.

Daniel Zapp (D)

Department of Ophthalmology, Technical University of Munich, Munich, Germany.

Ramin Khoramnia (R)

David J. Apple Center for Vision Research, Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH